Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

NCT07268586 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07268586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07268586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2025
Completion date
February 28, 2026
Enrollment
158 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction